Can it be worn with glasses?

Yes, the shield can be worn with or without glasses or goggles.

What is the lead time?

The average lead time is within 15 workdays for both peak and off-season.

Safety Anti Fog Face Protection Shield

Name: Safety Anti Fog Face Protection Shield
Brand: Hangzhou Yulan Medical Technology Co., Ltd.
SKU: 1923289932

Zhejiang, ChinaHangzhou Yulan Medical Technology Co., Ltd.

US$0.15-0.30

5,000 Pieces

Sample price:US$0.40/piece.Request sample

Product profile

Customization

Available

Mask Application

Personal Protective

Color

Blue

Model NO.

YL-FS-001

Mask Type

Safe-Type

Specification

32cm x 22cm

Trademark

OEM

Origin

China

Key features

Anti-Fog Technology: Nano-treated shield provides clear visibility for up to 5 years.

Customizable Options: Size, color, logo, and packaging design can be fully customized.

Comfortable Design: Equipped with foam band and elastic laminated soft non-woven cushion.

Universal Compatibility: Can be worn with or without glasses or goggles for maximum convenience.

Professional Certification: Certified with ISO 13485, CE 0120, and China GMP standards.

Safe Material: Made from odorless PET foam, ensuring safety during use.

Free Sample Service: Free samples available with freight collected service at your site.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryR&D Capabilities

Hangzhou Yulan Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 7 Years CertifiedNearest Port: Ningbo Port, Shanghai PortAverage Response Time: ≤1.98h

AI-Powered supplier vetting

SummaryHangzhou Yulan Medical Technology Co., Ltd. is a China-based trading company established in 2020 with two employees and stated export activity covering South America, Southeast Asia/Mideast, and Europe. It offers multiple medical products, including syringes, ambu bags, blood collection tubes, oxygen masks, face masks, urine bags, anesthesia masks, surgical gowns, thermometers, and nebulizer masks. The supplier reports a factory location in Xiamen, 10 production lines, 21–30 quality-control staff, and manual resuscitator output of 1,000,000 pieces, but the relationship between the trading company and reported factory is not clarified. An SGS audit is listed for February 14, 2025 to February 13, 2026, with audit type 1 and evaluation result 0; the meaning of these codes is not explained. The supplier states that it provides pre-sale and after-sale service, while certifications, R&D, customization, customer cases, and several quality and sustainability controls remain undocumented or marked unknown.

Supplier typeThe supplier is explicitly identified as a Trading Company and a Limited Company established in China in 2020. Its stated employee count is two, indicating a small operating organization, although the information does not establish whether it directly owns or operates the reported manufacturing site.

CertificationsAn SGS audit is recorded with validity from February 14, 2025 through February 13, 2026, but the audit type and evaluation result are provided only as codes whose meanings are not defined. The supplier management-system certification field is explicitly listed as NIL, so no management-system certification is evidenced.

After-Sales capabilityThe company description explicitly states that it provides pre-sale and after-sale service through experienced sales experts. This is direct evidence of stated service availability, though no service procedures, response metrics, or support infrastructure are provided.

Production capacityThe supplier reports 1,000,000 pieces of manual resuscitator output, 10 production lines, and a factory location identified as Xiamen Compower Medical Tech. Co., Ltd.; lead time is stated as within 15 workdays in both off-peak and peak seasons. However, the supplier is classified as a trading company and the manufacturing relationship is not explained, so the evidence supports reported production capacity rather than confirmed direct control.